10x Genomics Inc
(LTS:0A88)
$
14.72
0.6324 (4.47%)
Market Cap: 1.78 Bil
Enterprise Value: 1.46 Bil
PE Ratio: 0
PB Ratio: 2.46
GF Score: 60/100 10X Genomics Inc at UBS Genomics 2.0 and Medtech Innovations Summit (Virtual) Transcript
Aug 12, 2020 / 03:00PM GMT
Daniel Gregory Brennan
UBS Investment Bank, Research Division - Senior Equity Research Analyst of Healthcare Life Sciences
Good afternoon or really late good morning. Dan Brennan from UBS life science tools, diagnostics and pharma services analyst. Great to be joined here on stage at day 2 of the Genomics conference with Serge Saxonov as Co-Founder, CEO of 10x Genomics who, for everyone who's dialing in, knows well. Company reported last night, so it's timely. I know in the years past, when we've tried to have Serge come, it's kind of been a week earlier, so it's been quite difficult the week before the quarter. So I'm glad that we're able to have you be here in such a timely fashion. So certainly -- well, first off, welcome, and thank you for being here.
Serge Saxonov
10x Genomics, Inc. - Co-Founder, CEO & Director
Thanks, Dan. Glad to be here.
Daniel Gregory Brennan
UBS Investment Bank, Research Division - Senior Equity Research Analyst of Healthcare Life Sciences
Terrific. Terrific. And feel free, anyone
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot